StockData
CervoMed Inc. logo

CervoMed Inc. (CRVO) stock

CRVONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 5/30
$1.50−0.17 (-10.18%)

Close on Nov 17, 2026Market cap $22.68MP/E –Yield –

CervoMed total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

For fiscal 2013 it was $1.67M, up 166.7% from the year before.

Annual total debt

PeriodPeriod endValueChange
FY2013Dec 31, 2013$1.67M+166.7%
FY2010Dec 31, 2010$625.00K–

More CervoMed figures

See a number that looks wrong?